Models
BLISS GVS PHARMA LTDBLISSGVSPharmaceuticals & Biotechnology
₹31per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model₹31implied FY26 P/E 2.4× · EV/EBITDA 1.8×
Against CMP ₹721.00−95.8%close of 2026-09-10
Growth the CMP implies45.0%revenue, a year for 5 years, on your other inputs
Value after FY3190%share of enterprise value in the terminal
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.
Where the methods land · ₹ per share · the dashed line is the CMP
DCF, rate ±1 · growth ±1your model across the sensitivity grid
₹23₹45
52-week rangetraded range, a fact not a value
₹118₹726
From enterprise to equity · ₹ crore
| PV of FY27–FY31 free cash flow | 28 |
| PV of terminal value | 264 |
| Enterprise value | 292 |
| less net debt | 32 |
| less non-controlling interest | 0 |
| add non-operating investments | 0 |
| Equity value | 324 |
| ÷ 10.61 crore shares | ₹31 |
90% of the value sits after FY31. Usual when return on capital sits near the cost of capital; the 5 explicit years carry little of it.
Free cash flow, filed and modelled · ₹ '000 crore
Filed, cash from operations − capexModelled free cash flow to firm
Sensitivity · ₹ per share
Down Across| WACC ↓terminal growth → | 4.0% | 4.5% | 5.0% | 5.5% | 6.0% |
|---|---|---|---|---|---|
| 10.00% | 32 | 34 | 37 | 41 | 45 |
| 10.50% | 29 | 31 | 34 | 36 | 40 |
| 11.00% | 27 | 29 | 31 | 33 | 36 |
| 11.50% | 25 | 26 | 28 | 30 | 32 |
| 12.00% | 23 | 25 | 26 | 28 | 30 |
The outlined cell is your model. Green figures sit above the CMP of ₹721.00; n/a marks a terminal growth at or above the discount rate. Steps: WACC and terminal growth ±0.5 point, growth ±2, margin ±1.
Distribution of outcomes · 4,000 draws · growth, margin and the discount rate vary together
| 10th · 50th · 90th percentile, ₹ per share | (20) · 30 · 70 |
| Draws below the CMP | 100% |
| Rank correlation with revenue growth | −0.76 |
| Rank correlation with ebitda margin | +0.63 |
| Rank correlation with discount rate | −0.08 |
Each driver is drawn from a PERT distribution between the lowest and highest value across your scenarios (or ±50% growth, ±20% margin when there is one scenario), with the discount rate ±1.5 points. Seeded, so the same inputs give the same picture.
Projected cash flow to the firm · ₹ crore
History Forward| ₹ crore | FY23 | FY24 | FY25 | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 752 | 770 | 810 | 927 | 1,062 | 1,215 | 1,392 | 1,594 | 1,825 |
| growth % | 0.6 | 2.5 | 5.1 | 14.5 | 14.5 | 14.5 | 14.5 | 14.5 | 14.5 |
| EBITDA | 117 | 121 | 127 | 162 | 185 | 211 | 242 | 277 | 317 |
| margin % | 15.6 | 15.8 | 15.6 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 |
| less depreciation | (19) | (26) | (29) | (33) | (38) | (44) | (50) | (57) | (66) |
| EBIT | 99 | 95 | 97 | 128 | 146 | 168 | 192 | 220 | 252 |
| less tax on EBIT | (37) | (42) | (48) | (56) | (64) | (73) | |||
| NOPAT | 91 | 104 | 119 | 137 | 156 | 179 | |||
| add depreciation | 19 | 26 | 29 | 33 | 38 | 44 | 50 | 57 | 66 |
| less capex | (94) | (28) | (76) | (57) | (65) | (69) | (73) | (76) | (79) |
| less working-capital build | — | (82) | (94) | (107) | (123) | (140) | |||
| Free cash flow to firm | (59) | 124 | 30 | — | (4) | 1 | 7 | 15 | 25 |
| Discount factor | 0.949 | 0.855 | 0.770 | 0.694 | 0.625 | ||||
| Present value | (4) | 1 | 5 | 10 | 16 |
History columns are the filed years (free cash flow there is cash from operations − capex, as filed); the base year and everything to its right come from the engine. Forward is the explicit horizon of the model itself: 3, 5 or 10 years, then flat.
The three statements, projected · ₹ crore · debt held at 3, dividends at 8.3% of profit
| ₹ crore | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| EBIT | 128 | 146 | 168 | 192 | 220 | 252 |
| Interest at 8% on debt | (0) | (0) | (0) | (0) | (0) | |
| Profit before tax | 146 | 168 | 192 | 220 | 252 | |
| Profit after tax | 129 | 104 | 119 | 136 | 156 | 179 |
| Dividends | (11) | (9) | (10) | (11) | (13) | (15) |
| Balance sheet, year end | ||||||
| Cash | 35 | 22 | 13 | 8 | 10 | 21 |
| Working capital | 564 | 645 | 739 | 846 | 969 | 1,109 |
| Net block and other assets | 894 | 920 | 945 | 968 | 986 | 999 |
| Debt | 3 | 3 | 3 | 3 | 3 | 3 |
| Equity | 1,232 | 1,327 | 1,436 | 1,561 | 1,705 | 1,869 |
| Balance check | 0 | (0) | (0) | (0) | (0) | (0) |
| Cash flow | ||||||
| From operations | 60 | 69 | 79 | 91 | 104 | |
| Investing (capex) | (65) | (69) | (73) | (76) | (79) | |
| Financing (dividends) | (9) | (10) | (11) | (13) | (15) | |
| Net change in cash | (13) | (9) | (4) | 2 | 10 | |
| Free cash flow to equity | (4) | 1 | 7 | 15 | 25 | |
Other liabilities are held at their FY26 level, so the check tests only what the model moves: cash, working capital, net block and other assets, debt and equity. A non-zero check would mean the three statements no longer tie.
Scenarios side by side · ₹ per share
| Scenario | Template | Growth | Margin | Rate | Terminal | ₹ / share | vs CMP |
|---|---|---|---|---|---|---|---|
| Base · editing | DCF | 14.5% | 17.4% | 11.00% | 5% | ₹31 | (95.8)% |
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.